Adrenal disease

The use of prednisolone during Ramadan fasting in patients with adrenal insufficiency

Clin Endocrinol (Oxf)Published Prospective single-group study

Authors' conclusion

This study has demonstrated that converting patients with AI who are fasting for Ramadan from twice-daily hydrocortisone to prednisolone 5 mg daily at sahur was safe, with no major short-term adverse effects. Despite the higher equivalent glucocorticoid doses, patients experienced weight loss and no clinically significant change in blood pressure, sleep, biochemical parameters or quality of life. This study paves the way to trial even lower doses of prednisolone once daily in patients fasting for Ramadan with AI.

Study context

Population
Patients with adrenal insufficiency (AI) on twice-daily hydrocortisone, low or moderate risk, intending to fast for Ramadan; mean age 59.9 ± 15.0 years, 13 men; half with T2D with low IDF-DAR risk13 men
Participants
20 patients
Exposure
Prednisolone 5 mg once daily at sahur during Ramadan vs pre-Ramadan baseline on twice-daily hydrocortisone
  • Prednisolonen = 20
  • Baselinen = 20reference
Outcome
Change from baseline to end of Ramadan after conversion to prednisolone 5 mg once daily at sahur
Follow-up
End of Ramadan
Methodological detailsbefore–after comparison
  • Before–after comparison

Main finding

As reported in the abstract

Weight change

−1.1 ± 1.6 kg

p = .005

Urea change

0.80 ± 1.1 mmol/L

p = .005

Haematocrit change

0.011 ± 0.019 L/L

p = .019

Serum sodium change

−1.6 ± 3.0 mmol/L

p = .028

Observational data: associations, not effects.

Further findings

Quality of life (SF-36) · end of Ramadan vs baseline

Role limitation due to physical health, improvement
15.3 ± 21.6, p = .005
Bodily pain, improvement
8.8 ± 16.3, p = .031
Quality of life preserved in all domains

Completed full 29 days of fasting with no complications

Completed full fasting with no complications
Eighty-five percent

Safety

Completion of fasting without complications · 29 days of fasting

Completed full 29 days of fasting with no complications
85%

Original publication

The use of prednisolone during Ramadan fasting in patients with adrenal insufficiency. Clin Endocrinol (Oxf). Published 29 November 2023. doi:10.1111/cen.14999

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.